Delivery Order SPE2DR25D2214-SPE2DR26FV7E5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,248.01 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on September 8, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed price delivery order with no set-aside designation, placing performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $55,488.06 for Benlysta 200 mg/ml auto-injectors on September 17, 2025, with an ultimate completion date of October 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector units on September 11, 2025, with an ultimate completion date of October 2, 2025. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $3,082.67 and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Benlysta is a biologic medication used to treat systemic lupus erythematosus and lupus nephritis,...
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award leverages AmerisourceBergen's established relationship with DLA to supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for Benlysta 200 mg/ml auto-injector with a ceiling value of $9,248.01. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under the company's existing contract vehicle. The order is scheduled for completion by September 24, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. Benlysta (belimumab) is a biologic...
- The Defense Logistics Agency awarded a delivery order valued at $9,745.98 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on December 11, 2025. This non-competitive delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $6,497.32 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector on December 2, 2025, with completion expected by December 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. Benlysta is a biologic medication used to treat systemic lupus erythematosus, and this award represents a specific product delivery under the...
- The Defense Logistics Agency awarded a delivery order valued at $18,496.02 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors. The contract, issued on September 12, 2025, with an ultimate completion date of October 3, 2025, utilizes firm fixed-price pricing with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on September 10, 2025, with an ultimate completion date of October 1, 2025. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $6,165.34 and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. Benlysta (belimumab) is a monoclonal antibody used to treat systemic lupus erythematosus and is supplied via auto-injector,...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Benlysta 200 mg/mL auto-injector units. This competitively awarded, non-set-aside contract carries a ceiling value of $6,165.34 and is scheduled for completion by July 31, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Benlysta (belimumab) is a biologic immunosuppressant used to...
- SPE2DR25D2214Indefinite Delivery Contract
- SPE2DR25D2214-SPE2DR26FV7E5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Benlysta 200 mg/ml auto-injector with a ceiling value of $9,745.98. This is a firm fixed price delivery order with an ultimate completion date of January 21, 2026, and no set-aside designation was utilized. The contract represents a competitive award under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government, specifically supporting military and federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. Benlysta (belimumab) is a biologic immunosuppressant therapy, and the auto-injector formulation supports patients requiring self-administered systemic lupus erythematosus treatment. The award is executed from AmerisourceBergen's Conshohocken, Pennsylvania corporate office location, maintaining the company's established role as a critical pharmaceutical distributor for Department of Defense medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 12/28/25 |